Analytical Data
-
Gene name
EphB6
-
简介
EphB6 Protein, a kinase-defective receptor, binds ephrin-B1 and ephrin-B2, influencing cell adhesion and migration with nuanced effects. Its interaction with ephrin-B2 inhibits JNK activation, T-cell receptor-induced IL-2 secretion, and CD25 expression. EphB6 also interacts with CBL, EPHB1, and ligand-independently with FYN, highlighting its intricate role in cellular signaling pathways. EphB6 Protein, Mouse (HEK293, His) is the recombinant mouse-derived EphB6 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
Biological Activity
Measured by its binding ability in a functional ELISA. Immobilized Mouse EphB6 at 10 μg/mL (100 μL/well) can bind Mouse EFNB1. The ED50 for this effect is 0.3034 μg/mL. Measured by its binding ability in a functional ELISA. Immobilized Mouse EphB6 at 10 μg/mL (100 μL/well) can bind Mouse EFNB1. The ED50 for this effect is 0.3034 μg/mL.
-
Alternative Names
Ephrin type-B receptor 6; HEP; Tyrosine-protein kinase-defective receptor EPH-6; EPHB9
-
Species
Mouse
-
Source
HEK293
-
Tag
C-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
O08644
-
Expression Region
L33-S587
-
AA Sequence
LEEVLLDTTGETSEIGWLTYPPGGWDEVSVLDDQRRLTRTFEACHVAGLPPGSGQDNWLQTHFVERRGAQRAHIRLHFSVRACSSLGVSGGTCRETFTLYYRQADEPDGPDSIAAWHLKRWTKVDTIAADESFPASSSSSSWAVGPHRTGQRVGLQLNVKERSFGPLTQRGFYVAFQDTGACLALVAVKLFSYTCPSVLRAFASFPETQASGAGGASLVAAVGTCVAHAEPEEDGVGGQAGGSPPRLHCNGEGRWMVAVGGCRCQPGHQPARGDKLCQACPEGSYKALAGNVPCSPCPARSHSPDPAAPVCPCLQGFYRASSDPPEAPCTGPPSAPRELWFEVQGSALMLHWRLPQELGGRGDLLFNVVCKECGGHGEPSSGGMCRRCRDEVHFDPRQRGLTESRVLVGGLRAHVPYILEVQAVNGVSELSPDPPQAAAINVSTSHEVPSAVPVMHQVSRAANSITVSWPQPEQTNGNILDYQLRYYDQAEDESHSFTMTSETNTATVTRLSPGHIYGFQVRARTAAGHGPYGGKVYFQTLPQGELSSQLPEKLS
-
Protein Length
Extracellular Domain
-
Molecular Weight
66 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EphB6 is a member of the Eph receptor tyrosine kinase family, which plays a crucial role in cell signaling processes governing developmental and physiological functions, particularly in the nervous system. Unlike other Eph receptors, EphB6 exhibits a unique characteristic of functioning mainly as a negative regulator of cell signaling pathways. This regulation is significant in various biological contexts, including cell proliferation, differentiation, and migration, particularly in neural tissues. Research has indicated that EphB6 may be implicated in tumor biology, as its expression levels might influence cancer progression and metastasis. In the context of neurodegenerative diseases, EphB6's role in modulating synaptic functions and neuronal interactions presents a potential therapeutic target. The recombinant production of EphB6 protein is essential for studying its biochemical properties, interactions with ligands, and downstream signaling mechanisms. Such studies can facilitate a deeper understanding of its biological roles and may pave the way for novel therapeutic strategies in treating diseases where EphB6's function is altered. Therefore, characterizing EphB6 in detail through recombinant protein technology is vital for elucidating its potential implications in health and disease.
